Details of the Drug | DrugMAP

General Information of Drug (ID: DM7WGPW)

Drug Name

Wharton's Jelly-Mesenchymal Stem Cells

Synonyms

WJ-MSCs

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

TTD ID: D00HDZ

References

1	ClinicalTrials.gov (NCT04313322) Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells. U.S. National Institutes of Health.